The safety and efficacy of direct oral challenge in trimethoprim-sulfamethoxazole antibiotic allergy.

[1]  E. Phillips,et al.  The Penicillin Allergy Delabeling Program: A Multicenter Whole-of-Hospital Health Services Intervention and Comparative Effectiveness Study. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  E. Phillips,et al.  Oral Challenge with Trimethoprim-Sulfamethoxazole in Patients with "Sulfa" Antibiotic Allergy. , 2020, The journal of allergy and clinical immunology. In practice.

[3]  S. Knowles,et al.  Sulfonamide Hypersensitivity: Fact and Fiction. , 2019, The journal of allergy and clinical immunology. In practice.

[4]  E. Phillips,et al.  Beta-Lactam and Sulfonamide Allergy Testing Should Be a Standard of Care in Immunocompromised Host. , 2019, The journal of allergy and clinical immunology. In practice.

[5]  E. Phillips,et al.  Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicenter Evaluation , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  E. Macy,et al.  Self-reported antibiotic allergy incidence and prevalence: age and sex effects. , 2009, The American journal of medicine.

[7]  C. Giffen,et al.  Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ. , 2001, The Journal of infectious diseases.